Clinical trials: Social Anxiety Disorder

Social Anxiety Disorder

Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)

• Terminated
• Age: 18 to 65 years
• Phase 3
• Results posted

This study evaluates the safety and tolerability of PH94B with repeated dosing over a period of up to 12 months. Participating subjects will use PH94B up to 4 times a day when they encounter anxiety-provoking situations in daily…

Trial name

NCT05030350

Testing

PH94B

Where

3 sites in United States

Volunteers

481 people

Sponsor

VistaGen Therapeutics, Inc.